pramiracetam
pramiracetam structure
|
Common Name | pramiracetam | ||
|---|---|---|---|---|
| CAS Number | 68497-62-1 | Molecular Weight | 269.383 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 461.0±30.0 °C at 760 mmHg | |
| Molecular Formula | C14H27N3O2 | Melting Point | 47 °C | |
| MSDS | Chinese USA | Flash Point | 232.6±24.6 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of pramiracetamPramiracetam is a nootropic drug derived from piracetam, and is more potent. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries. IC50 Value: Target: in vitro: Pramiracetam sulfate did not exhibit any affinity in vitro for dopaminergic , GABAergic, serotoninergic, adrenergic, muscarinic, adenosine (IC50 > 10 uM), and benzodiazepine receptors (IC50 > 1 uM) binding sites [1].in vivo: In a double-blind, randomized design, two groups of six subjects each received alternating placebo and single 400, 800, 1,200, and 1,600 mg oral doses of pramiracetam after an overnight fast. Mean (+/- SD) peak plasma concentrations of the four dose groups (2.71 +/- 0.54, 5.40 +/- 1.34, 6.13 +/- 0.71, 8.98 +/- 0.71 micrograms/mL) were attained between two to three hours following drug administration [2]. Two doses of pramiracetam (7.5 mg/kg and 15 mg/kg) were administered daily prior to testing for 7 weeks in a 16-arm radial maze in which nine arms were baited with food [3]. |
| Name | Pramiracetam Hydrate |
|---|---|
| Synonym | More Synonyms |
| Description | Pramiracetam is a nootropic drug derived from piracetam, and is more potent. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries. IC50 Value: Target: in vitro: Pramiracetam sulfate did not exhibit any affinity in vitro for dopaminergic , GABAergic, serotoninergic, adrenergic, muscarinic, adenosine (IC50 > 10 uM), and benzodiazepine receptors (IC50 > 1 uM) binding sites [1].in vivo: In a double-blind, randomized design, two groups of six subjects each received alternating placebo and single 400, 800, 1,200, and 1,600 mg oral doses of pramiracetam after an overnight fast. Mean (+/- SD) peak plasma concentrations of the four dose groups (2.71 +/- 0.54, 5.40 +/- 1.34, 6.13 +/- 0.71, 8.98 +/- 0.71 micrograms/mL) were attained between two to three hours following drug administration [2]. Two doses of pramiracetam (7.5 mg/kg and 15 mg/kg) were administered daily prior to testing for 7 weeks in a 16-arm radial maze in which nine arms were baited with food [3]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 461.0±30.0 °C at 760 mmHg |
| Melting Point | 47 °C |
| Molecular Formula | C14H27N3O2 |
| Molecular Weight | 269.383 |
| Flash Point | 232.6±24.6 °C |
| Exact Mass | 269.210327 |
| PSA | 52.65000 |
| LogP | 0.39 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.495 |
| Storage condition | 2-8°C |
|
~69%
pramiracetam CAS#:68497-62-1 |
| Literature: Butler; Nordin; L'Italien; Zweisler; Poschel; Marriott Journal of Medicinal Chemistry, 1984 , vol. 27, # 5 p. 684 - 691 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933790090 |
|---|---|
| Summary | 2933790090. other lactams. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:9.0%. General tariff:20.0% |
|
The effects of cholinergic drugs support an avoidance learning hypothesis of brief footshock-induced analgesia.
Neuropharmacology 25(10) , 1161-6, (1986) Rats were tested for tail-flick responses and then immediately subjected to footshock for 30 sec. This procedure induced analgesia, i.e. prolonged the latency of the tail-flick response, which was max... |
|
|
The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
Behav. Brain Res. 33(1) , 79-82, (1989) The effects of the nootropic agent piracetam and its congeners oxiracetam, pramiracetam and aniracetam on the retention performance of mice in a passive-avoidance situation are dependent on the intens... |
|
|
Gas chromatographic assay of pramiracetam in human plasma using nitrogen specific detection.
J. Chromatogr. A. 274 , 346-9, (1983)
|
| N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide |
| Neupramir |
| Pramiracetam |
| Pramistar |
| Remen |
| Amacetam |
| N-[2-(Diisopropylamino)ethyl]-2-(2-oxo-1-pyrrolidinyl)acetamide |
| 1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo- |
| MFCD00867219 |
| N-[2-(diisopropylamino)ethyl]-2-oxo-1-pyrrolidineacetamide |
| N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide |
| N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide |
| N-[2-(Diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide |